United Kingdom

People: Cutera Inc (CUTR.OQ)

CUTR.OQ on NASDAQ Stock Exchange Global Select Market

6:30pm GMT
Change (% chg)

$0.32 (+1.80%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Reinstein, James 

Mr. James A. Reinstein is the President, Chief Executive Officer, Director of Cutera Inc. Prior to joining Cutera, Mr. Reinstein served as the CEO of Drawbridge Health Inc., a joint venture of GE Ventures and GE Healthcare. Prior to Drawbridge, He was the CEO of Aptus Endosystems from 2012 until its acquisition by Medtronic in 2015. From 2007-2012, he was the EVP and Chief Commercial Officer of Cyberonics, Inc. At Cyberonics, Mr. Reinstein drove the strategy for many of its departments including Research & Development, Clinical Research, and New Business Development and led a global commercial team of over 200 employees, growing revenues by 250% within three years. Prior to Cyberonics, Mr. Reinstein held a variety of management positions of increasing responsibility within Boston Scientific Corporation from 1990-2007, including Vice President and Regional Head of an Asian business unit; Country Director of Boston Scientific de Mexico; and European Head for its Neurovascular Division. He began his career with Proctor & Gamble.

Basic Compensation

Total Annual Compensation, USD 839,772
Restricted Stock Award, USD 5,422,940
Long-Term Incentive Plans, USD --
All Other, USD 2,019
Fiscal Year Total, USD 6,264,730

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --